Risk factors for gastrointestinal bleeding associated with low-dose aspirin

Best Practice and Research: Clinical Gastroenterology

Volumn 26, Issue 2, 2012, Pages 125-140

  Valkhoff, Vera E ^a   Sturkenboom, Miriam C J M ^a   Kuipers, Ernst J ^a,b  

^a ERASMUS MEDICAL CENTER   (Netherlands)

^b Department of Medical Informatics ^*  (Netherlands)

Author keywords

Gastrointestinal bleeding; Gastrointestinal haemorrhage; Low dose aspirin; Peptic ulcer disease; Predictors; Review; Risk factors

Indexed keywords

ACENOCOUMAROL; ACETYLSALICYLIC ACID; CLOPIDOGREL; NONSTEROID ANTIINFLAMMATORY AGENT; PHENPROCOUMON; PLACEBO; THROMBIN; WARFARIN;

AGE; ALCOHOL CONSUMPTION; ARTICLE; BODY MASS; CARDIOVASCULAR DISEASE; CEREBROVASCULAR DISEASE; COMORBIDITY; CORONARY ARTERY DISEASE; DIABETES MELLITUS; DRUG FEVER; DRUG MEGADOSE; DRUG SYNTHESIS; DYSPEPSIA; GASTROINTESTINAL HEMORRHAGE; GENDER; HEART ATRIUM FIBRILLATION; HELICOBACTER INFECTION; HUMAN; HYPERTENSION; ISCHEMIC HEART DISEASE; KIDNEY DISEASE; LOW DRUG DOSE; MEDICAL HISTORY; PANCYTOPENIA; PEPTIC ULCER; PETECHIA; PRACTICE GUIDELINE; REYE SYNDROME; RISK FACTOR; SMOKING; STOMACH DISEASE; STOMACH EROSION; STOMACH OBSTRUCTION; TINNITUS; TREATMENT DURATION; UPPER GASTROINTESTINAL BLEEDING; URTICARIA;

EID: 84860235576     PISSN: 15216918     EISSN: 15321916     Source Type: Journal    
DOI: 10.1016/j.bpg.2012.01.011     Document Type: Article

References (59)

1. E.R. Sprigg, K.M. Fleming, and R.F.A. Logan Is low dose aspirin use associated with iron deficiency anaemia? An analysis of data from the Health Survey for England 2006 Gut 58 Suppl II 2009 A91
2. M.T. McKenna, C.M. Michaud, C.J. Murray, and J.S. Marks Assessing the burden of disease in the United States using disability-adjusted life years Am J Prev Med 28 2005 415 423
3. C. Baigent, C. Sudlow, R. Collins, and R. Peto Collaborative meta-analysis of randomised trials of antiplatelet therapy for prevention of death, myocardial infarction, and stroke in high risk patients BMJ 324 2002 71 86
4. Final report on the aspirin component of the ongoing Physicians' Health Study. Steering Committee of the Physicians' Health Study Research Group N Engl J Med 321 1989 129 135
5. Swedish Aspirin Low-Dose Trial (SALT) of 75 mg aspirin as secondary prophylaxis after cerebrovascular ischaemic events. The SALT Collaborative Group Lancet 338 1991 1345 1349
6. J.L. Anderson, C.D. Adams, E.M. Antman, C.R. Bridges, R.M. Califf, and D.E. Casey Jr. American College of Cardiology (ACC)/American Heart Association (AHA) 2007 guidelines for the management of patients with unstable angina/non ST-elevation myocardial infarction: a report of the ACC/AHA Task Force on Practice Guidelines (Writing Committee to Revise the 2002 Guidelines for the Management of Patients With Unstable Angina/Non ST-Elevation Myocardial Infarction): developed in collaboration with the American College of Emergency Physicians, the Society for Cardiovascular Angiography and Interventions, and the Society of Thoracic Surgeons: endorsed by the American Association of Cardiovascular and Pulmonary Rehabilitation and the Society for Academic Emergency Medicine Circulation 116 2007 e148 304
7. C. Baigent, L. Blackwell, R. Collins, J. Emberson, J. Godwin, and R. Peto Aspirin in the primary and secondary prevention of vascular disease: collaborative meta-analysis of individual participant data from randomised trials Lancet 373 2009 1849 1860
8. R. Gao, and X. Li Risk assessment and aspirin use in Asian and Western populations Vasc Health Risk Manag 6 2010 943 956
9. E. Smecuol, M.I. Pinto Sanchez, A. Suarez, J.E. Argonz, E. Sugai, and H. Vazquez Low-dose aspirin affects the small bowel mucosa: results of a pilot study with a multidimensional assessment Clin Gastroenterol Hepatol 7 2009 524 529
10. P.J. Fortun, and C.J. Hawkey Nonsteroidal antiinflammatory drugs and the small intestine Curr Opin Gastroenterol 21 2005 169 175
11. T.A. Rockall, R.F. Logan, H.B. Devlin, and T.C. Northfield Incidence of and mortality from acute upper gastrointestinal haemorrhage in the United Kingdom. Steering Committee and members of the National Audit of Acute Upper Gastrointestinal Haemorrhage BMJ 311 1995 222 226
12. S. Hernandez-Diaz, and L.A. Rodriguez Incidence of serious upper gastrointestinal bleeding/perforation in the general population: review of epidemiologic studies J Clin Epidemiol 55 2002 157 163
13. S. Derry, and Y.K. Loke Risk of gastrointestinal haemorrhage with long term use of aspirin: meta-analysis BMJ 321 2000 1183 1187
14. M. Hayden, M. Pignone, C. Phillips, and C. Mulrow Aspirin for the primary prevention of cardiovascular events: a summary of the evidence for the U.S. Preventive Services Task Force Ann Intern Med 136 2002 161 172
15. K.R. McQuaid, and L. Laine Systematic review and meta-analysis of adverse events of low-dose aspirin and clopidogrel in randomized controlled trials Am J Med 119 2006 624 638
16. P.J. Roderick, H.C. Wilkes, and T.W. Meade The gastrointestinal toxicity of aspirin: an overview of randomised controlled trials Br J Clin Pharmacol 35 1993 219 226
17. V.L. Serebruany, S.R. Steinhubl, P.B. Berger, A.I. Malinin, J.S. Baggish, and D.L. Bhatt Analysis of risk of bleeding complications after different doses of aspirin in 192,036 patients enrolled in 31 randomized controlled trials Am J Cardiol 95 2005 1218 1222
18. R. Stalnikowicz-Darvasi Gastrointestinal bleeding during low-dose aspirin administration for prevention of arterial occlusive events. A critical analysis J Clin Gastroenterol 21 1995 13 16
19. S.M. Weisman, and D.Y. Graham Evaluation of the benefits and risks of low-dose aspirin in the secondary prevention of cardiovascular and cerebrovascular events Arch Intern Med 162 2002 2197 2202
20. L.A. Garcia Rodriguez, S. Hernandez-Diaz, and F.J. de Abajo Association between aspirin and upper gastrointestinal complications: systematic review of epidemiologic studies Br J Clin Pharmacol 52 2001 563 571
21. C.J. Hawkey Non-steroidal anti-inflammatory drugs and peptic ulcers BMJ 300 1990 278 284
22. F.L. Lanza, F.K. Chan, and E.M. Quigley Guidelines for prevention of NSAID-related ulcer complications Am J Gastroenterol 104 2009 728 738
23. D.L. Bhatt, J. Scheiman, N.S. Abraham, E.M. Antman, F.K. Chan, and C.D. Furberg American College of Cardiology Foundation (ACCF)/American College of Gastroenterology (ACG) /American Heart Association (AHA) 2008 expert consensus document on reducing the gastrointestinal risks of antiplatelet therapy and NSAID use: a report of the American College of Cardiology Foundation Task Force on Clinical Expert Consensus Documents Circulation 118 2008 1894 1909
24. S. Hernandez-Diaz, and L.A. Garcia Rodriguez Cardioprotective aspirin users and their excess risk of upper gastrointestinal complications BMC Med 4 2006 22
25. A. Lanas, and J. Scheiman Low-dose aspirin and upper gastrointestinal damage: epidemiology, prevention and treatment Curr Med Res Opin 23 2007 163 173
26. A. Lanas, E. Bajador, P. Serrano, J. Fuentes, S. Carreno, and J. Guardia Nitrovasodilators, low-dose aspirin, other nonsteroidal antiinflammatory drugs, and the risk of upper gastrointestinal bleeding N Engl J Med 343 2000 834 839
27. L. Cea Soriano, and L.A. Rodriguez Risk of upper gastrointestinal bleeding in a cohort of new users of low-dose asa for secondary prevention of cardiovascular outcomes Front Pharmacol 1 2010 126
28. A. Lanas, J. Fuentes, R. Benito, P. Serrano, E. Bajador, and R. Sainz Helicobacter pylori increases the risk of upper gastrointestinal bleeding in patients taking low-dose aspirin Aliment Pharmacol Ther 16 2002 779 786
29. W. Ng, W.M. Wong, W.H. Chen, H.F. Tse, P.Y. Lee, and K.C. Lai Incidence and predictors of upper gastrointestinal bleeding in patients receiving low-dose aspirin for secondary prevention of cardiovascular events in patients with coronary artery disease World J Gastroenterol 12 2006 2923 2927
30. K. Okada, M. Inamori, K. Imajo, H. Chiba, T. Nonaka, and T. Shiba Clinical study of upper gastrointestinal bleeding associated with low-dose aspirin in Japanese patients Hepatogastroenterology 56 2009 1665 1669
31. P. Serrano, A. Lanas, M.T. Arroyo, and I.J. Ferreira Risk of upper gastrointestinal bleeding in patients taking low-dose aspirin for the prevention of cardiovascular diseases Aliment Pharmacol Ther 16 2002 1945 1953
32. F.J. de Abajo, and L.A. Garcia Rodriguez Risk of upper gastrointestinal bleeding and perforation associated with low-dose aspirin as plain and enteric-coated formulations BMC Clin Pharmacol 1 2001 1
33. A. Lanas, L.A. Garcia-Rodriguez, M.T. Arroyo, F. Gomollon, F. Feu, and A. Gonzalez-Perez Risk of upper gastrointestinal ulcer bleeding associated with selective cyclo-oxygenase-2 inhibitors, traditional non-aspirin non-steroidal anti-inflammatory drugs, aspirin and combinations Gut 55 2006 1731 1738
34. H.T. Sorensen, L. Mellemkjaer, W.J. Blot, G.L. Nielsen, F.H. Steffensen, and J.K. McLaughlin Risk of upper gastrointestinal bleeding associated with use of low-dose aspirin Am J Gastroenterol 95 2000 2218 2224
35. J. Weil, D. Colin-Jones, M. Langman, D. Lawson, R. Logan, and M. Murphy Prophylactic aspirin and risk of peptic ulcer bleeding BMJ 310 1995 827 830
36. Thrombosis prevention trial: randomised trial of low-intensity oral anticoagulation with warfarin and low-dose aspirin in the primary prevention of ischaemic heart disease in men at increased risk. The Medical Research Council's General Practice Research Framework Lancet 351 1998 233 241
37. A.L. Gullov, B.G. Koefoed, and P. Petersen Bleeding during warfarin and aspirin therapy in patients with atrial fibrillation: the AFASAK 2 study. Atrial fibrillation aspirin and anticoagulation Arch Intern Med 159 1999 1322 1328
38. M. Hurlen, M. Abdelnoor, P. Smith, J. Erikssen, and H. Arnesen Warfarin, aspirin, or both after myocardial infarction N Engl J Med 347 2002 969 974
39. W.C. Johnson, and W.O. Williford Benefits, morbidity, and mortality associated with long-term administration of oral anticoagulant therapy to patients with peripheral arterial bypass procedures: a prospective randomized study J Vasc Surg 35 2002 413 421
40. K. Buresly, M.J. Eisenberg, X. Zhang, and L. Pilote Bleeding complications associated with combinations of aspirin, thienopyridine derivatives, and warfarin in elderly patients following acute myocardial infarction Arch Intern Med 165 2005 784 789
41. S. Yusuf, F. Zhao, S.R. Mehta, S. Chrolavicius, G. Tognoni, and K.K. Fox Effects of clopidogrel in addition to aspirin in patients with acute coronary syndromes without ST-segment elevation N Engl J Med 345 2001 494 502
42. P.B. Berger, D.L. Bhatt, V. Fuster, P.G. Steg, K.A. Fox, and M. Shao Bleeding complications with dual antiplatelet therapy among patients with stable vascular disease or risk factors for vascular disease: results from the Clopidogrel for High Atherothrombotic Risk and Ischemic Stabilization, Management, and Avoidance (CHARISMA) trial Circulation 121 2010 2575 2583
43. Recommendations for the medical management of osteoarthritis of the hip and knee: 2000 update. American College of Rheumatology Subcommittee on Osteoarthritis guidelines Arthritis Rheum 43 2000 1905 1915
44. F.L. Lanza A guideline for the treatment and prevention of NSAID-induced ulcers. Members of the Ad Hoc Committee on practice parameters of the American College of Gastroenterology Am J Gastroenterol 93 1998 2037 2046
45. National Institute for Clinical Excellence (NICE) Guidance on the use of cyclo-oxygenase (Cox) II selective inhibitors, celecoxib, rofecoxib, meloxicam and etodolac for osteoarthritis and rheumatoid arthritis (Technology appraisal guidance 27) 2001 NICE (replaced by CG59 en CG 79) London
46. C. Deighton, R. O'Mahony, J. Tosh, C. Turner, and M. Rudolf Management of rheumatoid arthritis: summary of NICE guidance BMJ 338 2009 b702
47. H.J. Moens, J.J. van Croonenborg, M.J. Al, P.M. van den Bemt, J. Lourens, and M.E. Numans Guideline 'NSAID use and the prevention of gastric damage' Ned Tijdschr Geneeskd 148 2004 604 608
48. M. Udd, P. Miettinen, A. Palmu, M. Heikkinen, E. Janatuinen, and P. Pasanen Analysis of the risk factors and their combinations in acute gastroduodenal ulcer bleeding: a case-control study Scand J Gastroenterol 42 2007 1395 1403
49. S. Santolaria, A. Lanas, R. Benito, M. Perez-Aisa, M. Montoro, and R. Sainz Helicobacter pylori infection is a protective factor for bleeding gastric ulcers but not for bleeding duodenal ulcers in NSAID users Aliment Pharmacol Ther 13 1999 1511 1518
50. F.K. Chan, S.C. Chung, B.Y. Suen, Y.T. Lee, W.K. Leung, and V.K. Leung Preventing recurrent upper gastrointestinal bleeding in patients with Helicobacter pylori infection who are taking low-dose aspirin or naproxen N Engl J Med 344 2001 967 973
51. J.P. Kelly, D.W. Kaufman, J.M. Jurgelon, J. Sheehan, R.S. Koff, and S. Shapiro Risk of aspirin-associated major upper-gastrointestinal bleeding with enteric-coated or buffered product Lancet 348 1996 1413 1416
52. S.S. Uppalapati, J.D. Boylan, and J. Stoltzfus Risk factors involved in patients with bleeding peptic ulcers: a case-control study Dig Dis Sci 54 2009 593 598
53. D.Y. Graham, J.L. Smith, H.J. Spjut, and E. Torres Gastric adaptation. Studies in humans during continuous aspirin administration Gastroenterology 95 1988 327 333
54. J.L. Anderson, C.D. Adams, E.M. Antman, C.R. Bridges, R.M. Califf, and D.E. Casey Jr. 2011 American College of Cardiology Foundation (ACCF)/American Heart Association (AHA) Focused Update Incorporated Into the ACCF/AHA 2007 Guidelines for the Management of Patients With Unstable Angina/Non-ST-Elevation Myocardial Infarction: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines Circulation 123 2011 e426 579
55. R.C. Becker, T.W. Meade, P.B. Berger, M. Ezekowitz, C.M. O'Connor, and D.A. Vorchheimer The primary and secondary prevention of coronary artery disease: American College of Chest Physicians evidence-based clinical practice guidelines (8th Edition) Chest 133 2008 776S 814S
56. A.N. Barkun, M. Bardou, E.J. Kuipers, J. Sung, R.H. Hunt, and M. Martel International consensus recommendations on the management of patients with nonvariceal upper gastrointestinal bleeding Ann Intern Med 152 2010 101 113
57. C.W. Hamm, J.P. Bassand, S. Agewall, J. Bax, E. Boersma, and H. Bueno European Society of Cardiology (ESC) guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation: the Task Force for the management of acute coronary syndromes (ACS) in patients presenting without persistent ST-segment elevation of the European Society of Cardiology (ESC) Eur Heart J 2011
58. V.E. Valkhoff, E.M. van Soest, M.C. Sturkenboom, and E.J. Kuipers Time-trends in gastroprotection with nonsteroidal anti-inflammatory drugs (NSAIDs) Aliment Pharmacol Ther 31 2010 1218 1228
59. E.M. van Soest, V.E. Valkhoff, G. Mazzaglia, R. Schade, M. Molokhia, and J.L. Goldstein Suboptimal gastroprotective coverage of NSAID use and the risk of upper gastrointestinal bleeding and ulcers: an observational study using three European databases Gut 2011